These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 18926235)

  • 1. Platelet-derived growth factor inhibition--a new treatment of pulmonary hypertension in congenital diaphragmatic hernia?
    Frenckner B; Broomé M; Lindström M; Radell P
    J Pediatr Surg; 2008 Oct; 43(10):1928-31. PubMed ID: 18926235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination pharmacotherapy for severe neonatal pulmonary hypertension.
    Filan PM; McDougall PN; Shekerdemian LS
    J Paediatr Child Health; 2006 Apr; 42(4):219-20. PubMed ID: 16630327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of rebound and chronic pulmonary hypertension with oral sildenafil in an infant with congenital diaphragmatic hernia.
    Keller RL; Hamrick SE; Kitterman JA; Fineman JR; Hawgood S
    Pediatr Crit Care Med; 2004 Mar; 5(2):184-7. PubMed ID: 14987351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transient effect of epoprostenol and sildenafil combined with iNO for pulmonary hypertension in congenital diaphragmatic hernia.
    De Luca D; Zecca E; Vento G; De Carolis MP; Romagnoli C
    Paediatr Anaesth; 2006 May; 16(5):597-8. PubMed ID: 16677275
    [No Abstract]   [Full Text] [Related]  

  • 5. An evidence-based approach to the management of pulmonary arterial hypertension.
    Archer SL; Michelakis ED
    Curr Opin Cardiol; 2006 Jul; 21(4):385-92. PubMed ID: 16755209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular effects of sildenafil in neonates and infants with congenital diaphragmatic hernia and pulmonary hypertension.
    Noori S; Friedlich P; Wong P; Garingo A; Seri I
    Neonatology; 2007; 91(2):92-100. PubMed ID: 17344658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhalation of nitric oxide as a treatment of pulmonary hypertension in congenital diaphragmatic hernia.
    Henneberg SW; Jepsen S; Andersen PK; Pedersen SA
    J Pediatr Surg; 1995 Jun; 30(6):853-5. PubMed ID: 7666321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of imatinib mesylate in the treatment of pulmonary arterial hypertension.
    Chhina MK; Nargues W; Grant GM; Nathan SD
    Future Cardiol; 2010 Jan; 6(1):19-35. PubMed ID: 20014985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PDGF receptor and its antagonists: role in treatment of PAH.
    Grimminger F; Schermuly RT
    Adv Exp Med Biol; 2010; 661():435-46. PubMed ID: 20204747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet-derived growth factor receptor-tyrosine kinase inhibitor, imatinib, is effective for treating pulmonary hypertension induced by pulmonary tumor thrombotic microangiopathy.
    Minatsuki S; Miura I; Yao A; Abe H; Muraoka H; Tanaka M; Imamura T; Inaba T; Maki H; Hatano M; Kinugawa K; Yao T; Fukayama M; Nagai R; Komuro I
    Int Heart J; 2015; 56(2):245-8. PubMed ID: 25740390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sildenafil use in congenital diaphragmatic hernia.
    Hunter L; Richens T; Davis C; Walker G; Simpson JH
    Arch Dis Child Fetal Neonatal Ed; 2009 Nov; 94(6):F467. PubMed ID: 19846401
    [No Abstract]   [Full Text] [Related]  

  • 12. Imatinib mesylate has the potential to exert its efficacy by down-regulating the plasma concentration of platelet-derived growth factor in patients with pulmonary arterial hypertension.
    Hatano M; Yao A; Shiga T; Kinugawa K; Hirata Y; Nagai R
    Int Heart J; 2010 Jul; 51(4):272-6. PubMed ID: 20716845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PDGF receptor blocker for pulmonary hypertension: a new agent in therapeutic arsenal.
    Mathew R
    Expert Opin Investig Drugs; 2012 Feb; 21(2):139-42. PubMed ID: 22217204
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment with imatinib for refractory PAH].
    Nakamura K; Akagi S; Sarashina T; Ogawa A; Matsubara H; Ito H
    Nihon Yakurigaku Zasshi; 2014 Apr; 143(4):173-7. PubMed ID: 24717604
    [No Abstract]   [Full Text] [Related]  

  • 15. Current pharmacological treatment of pulmonary arterial hypertension.
    Steiropoulos P; Trakada G; Bouros D
    Curr Clin Pharmacol; 2008 Jan; 3(1):11-9. PubMed ID: 18690874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis and treatment of pulmonary hypertension in infancy.
    Steinhorn RH
    Early Hum Dev; 2013 Nov; 89(11):865-74. PubMed ID: 24083892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of imatinib in the treatment of pulmonary hypertension.
    Mucke H
    Drugs Today (Barc); 2013 Mar; 49(3):203-11. PubMed ID: 23527324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "Treat-to-target" in pulmonary arterial hypertension and the use of extracorporeal membrane oxygenation as a bridge to transplantation.
    Hoeper MM
    Eur Respir Rev; 2011 Dec; 20(122):297-300. PubMed ID: 22130824
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pulmonary hypertension and fetal circulation after severe congenital diaphragmatic hernia (author's transl)].
    Mselati JC; Besson-Leaud M; Revillon Y; Laufenburger A; Lavaud J; Cloup M; Pellerin D
    Chir Pediatr; 1979; 20(1):13-9. PubMed ID: 436190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The treatment of idiopathic pulmonary artery hypertension and its relation to systemic scleroderma].
    Humbert M
    Rev Med Interne; 2007 Dec; 28 Suppl 4():S273-6. PubMed ID: 17961866
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.